GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation

Medicine & Life Sciences

• GTP-Binding Proteins 78%
• Insulin 66%
• Glucose 61%
• Protein Domains 59%
• Facilitative Glucose Transport Proteins 45%
• Proteins 35%
• G-Protein-Coupled Receptor Kinases 29%
• Glucose Transporter Type 4 29%
• Heterotrimeric GTP-Binding Proteins 26%
• 3T3-L1 Cells 23%
• Deoxyglucose 22%
• Protein Subunits 22%
• Microinjections 21%
• G-Protein-Coupled Receptors 19%
• Adenoviridae 19%
• Adipocytes 18%
• Anti-Idiotypic Antibodies 16%
• Small Interfering RNA 16%
• Insulin Resistance 16%
• Phosphotransferases 15%

Chemical Compounds

• Insulin Derivative 100%
• Glucose 72%
• Protein 40%
• Silencing RNA 21%